Last updated: July 13, 2026
Device clinics process thousands of transmissions annually, and a substantial portion of alerts are clinically non-relevant. That volume creates a compounding problem: clinicians habituate to noise, and genuinely critical events, such as new-onset atrial fibrillation, ventricular tachycardia, or lead malfunction, risk being buried in the queue.
The 2026 Heart Rhythm Society meeting surfaced concrete data on the scope of the problem. An EHRA 2026 analysis found that even in AI-equipped devices, 32.9% of episodes remained non-actionable due to guideline-based interpretation gaps and signal-detection issues. Manufacturer-level filtering, while improved, does not eliminate the residual noise that burdens clinical teams.
A manufacturer-agnostic AI layer addresses what device-embedded filtering cannot. AI-driven triage can lead to an 80% reduction in alert response times while maintaining 99.9% data reliability. Rhythm360 achieves this through computer vision, redundant data feeds, and AI-powered extrapolation that ingests diverse data types, including APIs, HL7, XML, and unstructured PDFs, and normalizes them into a single prioritized queue. When an OEM server goes offline, the redundant feed architecture ensures no transmission is silently dropped.
The clinical impact is direct. A nurse receives a prioritized notification of new-onset AFib on a Saturday morning. By Saturday afternoon, the patient is on anticoagulants or has had their device reprogrammed. Manual, portal-by-portal workflows would likely have delayed that intervention until the following business week.
Each CIED manufacturer has developed proprietary nomenclature, technical standards, and communication protocols to describe similar if not identical features and functionalities, requiring clinicians to pull together data from multiple vendors. The moment a practice implants devices from more than one OEM, such as Medtronic, Boston Scientific, Abbott, or Biotronik, staff must log into separate, non-interoperable portals. That fragmentation creates data silos and unsustainable administrative burden.
The absence of interoperability standards impedes seamless data exchange between devices, platforms, and protocols from different manufacturers, creating data silos that hinder comprehensive analysis and limit clinical utility of remote monitoring data. A vendor-neutral aggregation layer resolves this at the infrastructure level rather than requiring staff to reconcile discrepancies manually.
The table below summarizes how the RhythmScience platform translates into measurable Rhythm360 outcomes across the criteria that matter most to multi-OEM practices.
| Evaluation Criteria | RhythmScience Platform Capability | Rhythm360 Outcome | 2026 Source |
|---|---|---|---|
| Vendor neutrality | Ingests data from all major OEMs (Medtronic, Boston Scientific, Abbott, Biotronik) via API, HL7, XML, and PDF computer vision | Single dashboard eliminates redundant portal logins across all device manufacturers | UCM White Paper, 2025 |
| Data transmissibility | Redundant data feeds and AI-powered extrapolation as fail-safe against OEM server downtime | >99.9% transmissibility rate | HRS 2026 Platform Comparison |
| Alert response time | AI triage prioritizes clinically significant events, with optional 24/7/365 CCT oversight | Up to 80% reduction in critical alert response times | HRS 2026 Platform Comparison |
| EHR integration depth | Bi-directional HL7/FHIR flows with Epic, Cerner, Athenahealth, eClinicalWorks, and others | Device data lands in clinical workflow, and billing documentation is generated automatically at report completion | UCM White Paper, 2025 |
The real-world stakes of vendor-neutral aggregation appear clearly in the University of Chicago Medicine experience. UCM reviewed more than 73,000 reports annually through Rhythm360 in calendar year 2025, averaging more than 18,000 reports per quarter. At that volume, a fragmented portal workflow would be operationally untenable. Centralized aggregation made it possible to identify abnormalities earlier: “We are able to address these issues earlier; rather than waiting for a 3-month visit, we can call patients in for evaluation.”
The 2026 CMS Physician Fee Schedule introduced two new RPM codes that materially change revenue capture for cardiology practices. CMS finalized CPT 99445 for device supply and data transmission covering 2 to 15 days within a 30-day period and CPT 99470 for the first 10 minutes of RPM treatment management services, both effective January 1, 2026. These codes remove the prior 16-day transmission barrier, so patients who previously generated zero reimbursement now produce billable events.
Rate increases compound the opportunity. In 2026, Medicare updated RPM CPT codes with increased reimbursement rates. Automatic tracking of billing windows can generate additional revenue for CIED programs.
Manual workflows consistently underperform automated ones. Automated workflows can improve capture rates for codes such as 99457 and reduce denials. On a 500-patient panel, this improvement can translate to significant additional annual revenue from better capture of billable services, with additional recovery from associated codes.
Rhythm360 automates CPT code capture and documentation at the point of report completion, helping practices recover previously lost revenue. “We have improved billing and accountability for our patients after the integration,” noted a UCM clinician following Rhythm360 implementation. This optimization has driven the revenue increases noted earlier in practices that have implemented the platform.
Effective EHR integration in 2026 requires more than a one-way data push. Modern API-driven integration built on the FHIR standard requests current patient context from the EHR at the moment of review rather than relying on cached snapshots, enabling medications, diagnoses, hospitalizations, labs, and cardiac function data to refresh automatically every time a report is opened. When a device alert confirms an AF episode, the clinical decision depends on anticoagulation status and recent hospitalization history, data that batch-sync integrations may not surface in time.
Rhythm360 supports bi-directional HL7/FHIR flows with Epic, Cerner, Athenahealth, eClinicalWorks, Greenway Health, and other systems. Implementation, including integration setup, typically takes from a few days to a few weeks, a timeline that compares favorably to the 2 to 3 weeks typically required for the device and system integration phase of cardiology EHR implementations.
For on-call clinicians, Rhythm360’s secure, HIPAA-compliant mobile app allows review of transmissions, report signing, and care coordination from any location. Best practices for mobile access security in cardiac remote monitoring include enforcing TLS 1.2 or higher for device telemetry and admin portals, and suppressing PHI in notifications in favor of in-app secure messaging. Rhythm360’s mobile architecture is built to these standards.
Rhythm360 serves the full spectrum of cardiology providers, and practice-size considerations differ meaningfully across segments.
For solo EP clinics and small practices, the primary concern is eliminating the administrative burden of multi-OEM portal management without adding headcount. Rhythm360’s SaaS-based pricing scales with clinic size and platform usage, and the centralized dashboard reduces reliance on a single “super-user,” which protects business continuity when key staff are unavailable.
For mid-size cardiology groups managing hundreds of CIED patients, the combination of automated billing documentation and AI alert triage directly addresses the revenue leakage and burnout that drive technician turnover. Some practices have seen improvements in billing efficiency with AI integration in remote monitoring.
For large health systems, scalability is the defining requirement. At the volume UCM demonstrated, with stable dismissal rates across all 73,000+ annual reports, scalable monitoring becomes operationally critical. As Andrew Beaser, MD, Associate Professor of Medicine at UCM, noted, “Decision support, including AI-assisted decision support, will become increasingly important as data volumes grow.”
The AAMC estimates a shortage of between 5,800 and 15,800 cardiologists by 2030, which makes scalable infrastructure a strategic imperative regardless of practice size.
The total value of a remote monitoring platform extends beyond licensing cost. Three measurable dimensions define return on investment for Rhythm360 implementations.
Onboarding speed: The rapid implementation timeline noted earlier, days to weeks rather than months, includes bi-directional EHR integration in the onboarding process and avoids the per-integration fees that commonly range from $500 to $2,000 per connection in standalone cardiology EHR implementations.
Staffing relief: Automated data ingestion, report generation, and billing documentation reduce the hours device technicians spend on manual retrieval and transcription. AI-driven triage delivers the response-time improvements documented earlier, shifting clinical staff from reactive queue management to proactive patient care.
Revenue capture: Practices implementing Rhythm360 have achieved up to a 300% increase in revenue through optimized CPT code capture, improved staff efficiency, and the addition of HF/HTN RPM service lines. A 500-patient cardiology RPM program can leave significant revenue on the table when manual tracking is used for billing rules. Rhythm360’s automated workflows close that gap systematically.
Cardiology practice administrators and EP directors can use the following checklist to evaluate whether a remote monitoring platform is ready for 2026 requirements.
If any answer is uncertain, that gap represents clinical, operational, or financial risk. Walk through how Rhythm360 addresses each checklist item for your specific practice configuration.
The HRS 2026 data cited earlier confirmed that manufacturer-level filtering alone leaves a meaningful residual of non-actionable alerts. A manufacturer-agnostic AI analysis layer applied on top of device-embedded filtering can substantially reduce residual false-positive alerts while maintaining the high sensitivity required for patient safety. The platform’s multi-layer ingestion architecture, detailed earlier, delivers the 80% response-time reduction and >99.9% transmissibility documented in HRS 2026 data. The platform’s optional 24/7/365 oversight by certified cardiac technicians provides an additional clinical layer for after-hours triage.
The OEM portal fragmentation described earlier, including separate logins, inconsistent formats, and manual consolidation, scales poorly as patient volume grows. Vendor-neutral aggregation resolves this by ingesting data from all major OEMs through a combination of APIs, HL7, XML, and PDF parsing via computer vision, then normalizing it into a single structured dashboard. Rhythm360 supports this model across Medtronic, Boston Scientific, Abbott, Biotronik, and others, and extends the same unified view to HF and HTN remote physiological monitoring data. UCM’s implementation, processing the volume detailed earlier with stable dismissal rates, demonstrates that centralized aggregation is operationally viable even at high volume.
The primary driver of 99457 underperformance in manual workflows is incomplete time tracking, so manual workflows often miss opportunities to bill 99457 on eligible patient-months. The automated time tracking and documentation generation detailed in the billing section eliminates the manual logging gaps that cause 99457 underperformance. Rhythm360 automates CPT code identification and documentation generation, including the 2026 codes introduced earlier (99445 and 99470), so that billable events are captured without requiring staff to maintain separate time logs. RVU increases for certain codes add further upside for CIED programs that track interrogation windows automatically.
The mobile and EHR capabilities detailed earlier, including HIPAA-compliant alerts, real-time clinical context, and mobile report signing, ensure on-call teams can act on alerts without returning to a workstation. Rhythm360’s mobile app supports these capabilities and integrates bi-directionally with Epic, Cerner, Athenahealth, and other major EHR systems, so the clinical record is updated in real time regardless of where the clinician is located when they act on an alert.
Cardiology practices in 2026 face a convergence of pressures: growing CIED patient populations, a projected cardiologist shortage, new CPT codes that reward automated tracking, and OEM data fragmentation that manual workflows cannot sustainably manage. The evaluation framework presented above, centered on vendor neutrality, AI triage, and billing automation, defines the difference between a platform that adds administrative complexity and one that removes it.
Rhythm360 delivers on all three pillars: unified data aggregation across OEMs, AI triage that achieves the response-time improvements documented above, and automated billing that captures the 2026 code set. The platform delivers the alert-response improvements and revenue gains documented above, and UCM’s high-volume implementation demonstrates earlier intervention and improved accountability at scale.
See how Rhythm360 performs against your specific OEM mix, patient volume, and EHR environment in a personalized demo.
